Increasing demand for personalized medicine and advancements in genetic engineering technologies are expected to drive the growth of the rat model market. Additionally, rising prevalence of chronic diseases and the need for more accurate and reliable preclinical models are significant growth drivers for the market. Furthermore, the growing focus on developing new therapies for various diseases is creating lucrative opportunities for market players in the rat model industry.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Type, Technology, Service, Application, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Charles River Laboratories, genOway, TransViragen,, Laboratory of America Holdings, Janvier Labs, Taconic Biosciences,, Biomere, Cyagen Biosciences |
The stringent regulations and ethical concerns regarding the use of animals in research could restrain the growth of the rat model market. Moreover, the high cost of maintenance and housing of rats, as well as the lack of standardization in experimental procedures, are major restraints that could hinder market growth in the coming years.